These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7347239)

  • 1. [Use of the exercise test for determining the optimal dose of prolonged-action nitrates in patients with angina pectoris].
    Martsevich SIu; Vygodin VA; Metelitsa VI
    Ter Arkh; 1981; 53(12):22-6. PubMed ID: 7347239
    [No Abstract]   [Full Text] [Related]  

  • 2. Is the use of long acting nitrates beneficial in the patient with angina pectoris? (The negative side).
    Goldstein RE
    Cardiovasc Clin; 1977; 8(1):149-58. PubMed ID: 403005
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].
    Kośmicki M; Szwed H; Kowalik I; Sadowski Z
    Pol Merkur Lekarski; 2002 Jul; 13(73):52-5. PubMed ID: 12362508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].
    Ciopor M; Fischer A; Turina J; Hess OM
    Praxis (Bern 1994); 1997 Nov; 86(47):1849-53. PubMed ID: 9480502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
    Rotrekl P; Vlasínová J; Manousek J; Semrád B; Rysavý F; Lupínek Z; Meluzín J; Vlasicová I; Pirochtová I; Bocek O
    Vnitr Lek; 1993 Sep; 39(9):856-64. PubMed ID: 8212639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disparate efficacy of isosorbide dinitrate, in sustained-release form, during acute and chronic administration (author's transl)].
    Blasini R; Brügmann U; Mannes A; Froer KL; Hall D; Rudolph W
    Herz; 1980 Oct; 5(5):298-305. PubMed ID: 7450664
    [No Abstract]   [Full Text] [Related]  

  • 7. Sustained hemodynamic and antianginal effects of high dose oral isosorbide dinitrate.
    Aronow S
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2483-6. PubMed ID: 7422537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tolerance for the antianginal effect of nitrates. Approaches to its study].
    Martsevich SIu; Shakarova SSh; Metelitsa VI; Strel'tsov AA; Vygodin VA
    Ter Arkh; 1984; 56(9):46-50. PubMed ID: 6515547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance to the hemodynamic and antianginal effects of the organic nitrates.
    Parker JO
    Z Kardiol; 1985; 74 Suppl 1():45-9. PubMed ID: 3922142
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of the effects of depot peroral and transdermal administration of nitrate preparations].
    Camek R; Karetová D; Bultas J; Krupicka P; Boudĭk F; Fabian E
    Vnitr Lek; 1988 Feb; 34(2):122-9. PubMed ID: 3129873
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of isosorbide dinitrate tape on exercise tolerance of patients with angina pectoris.
    Saito M; Nobuyoshi M; Nakamura N; Nishiyama S; Haze K; Hiramori K; Ikeda M
    Arzneimittelforschung; 1983; 33(9):1301-5. PubMed ID: 6685512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of the efficacy and duration of action of 2 isosorbide dinitrate preparations].
    Magelli C; Marzocchi A; Ferretti RM; Bassein L; Magnani B
    Cardiologia; 1982; 27(6):609-14. PubMed ID: 6892440
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
    Kośmicki M; Sadowski Z
    Przegl Lek; 2000; 57(9):455-8. PubMed ID: 11199864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation].
    Kappenberger L; Fellmann H; Nager F
    Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035
    [No Abstract]   [Full Text] [Related]  

  • 15. [Duration of effects of isosorbide dinitrate retard in coronary disease].
    Raab C; Schindler J; Rahlfs VW
    Med Welt; 1977 Nov; 28(44):1807-9. PubMed ID: 593121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Evaluation by means of atrial pacing of the hemodynamic and clinical effects of a delayed-action isosorbide dinitrate preparation in patients with angina pectoris].
    Ray M; Salerno JA; Chimienti M; Storti D; Fici F; Tavazzi L; Bobba P
    Minerva Cardioangiol; 1977 Jan; 23(1):53-62. PubMed ID: 840399
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of nitro-retard preparations during rest and ergometric exercise in patients with coronary heart disease].
    Boutefeu JM; Righetti A; Rutishauser W
    Med Welt; 1980 Aug; 31(35):1251-4. PubMed ID: 7421560
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dynamic ECG evaluation of the activity of long-acting isosorbide dinitrate in patients with unstable angina (author's transl)].
    Pedone V; Bellotti L; Belluzzi D; Di Biase G
    G Ital Cardiol; 1981; 11(10):1450-5. PubMed ID: 7042436
    [No Abstract]   [Full Text] [Related]  

  • 19. What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
    Kośmicki M; Sadowski Z; Szwed H; Kowalik I
    Med Sci Monit; 2000; 6(4):763-8. PubMed ID: 11208406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodynamic measurements and exercise testing to assess the development of tolerance against slow-release isosorbide dinitrate.
    Weidemann H; Schuon J; Schober B
    Z Kardiol; 1983; 72 Suppl 3():229-32. PubMed ID: 6666226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.